Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondriopathies.

J Finsterer1

  • 1Neurological Department, Krankenanstalt Rudolfstiftung, Vienna, Austria. duarte@aonmail.at

European Journal of Neurology
|March 11, 2004
PubMed
Summary
This summary is machine-generated.

Mitochondriopathies (MCPs) are genetic or acquired disorders affecting energy production. Diagnosis is challenging due to varied symptoms, but understanding pathophysiology offers hope for future therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nonspecific lower back pain in overhead athletes is multifactorial and is not solely determined by the type and intensity of the sport.

South African journal of sports medicine·2026
Same author

The spectrum of developmental and epileptic encephalopathies and their genetic heterogeneity are much broader than previously thought.

The Medical journal of Malaysia·2026
Same author

Bilateral hack sign not necessarily implies paraparesis.

Neurologia·2025
Same author

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios can only predict the severity of COVID-19 if the criteria for a biomarker are met.

The Medical journal of Malaysia·2025
Same author

The spectrum of ophthalmologic abnormalities in MELAS is broader than expected.

Archivos de la Sociedad Espanola de Oftalmologia·2025
Same author

In Patients not Suitable for Generalised Anaesthesia, Surgery for Necrotising Fasciitis under Spinal Anaesthesia should be Considered.

Malaysian orthopaedic journal·2025
Same journal

Blood Pressure Control With Clevidipine Is Associated With Hematoma Volume Reduction in Acute Hypertensive Intracerebral Hemorrhage: A Single-Center Prospective Cohort Study.

European journal of neurology·2026
Same journal

CGRP-Targeted Therapy in Vestibular Migraine-How Strong Is the Evidence?

European journal of neurology·2026
Same journal

Direct Thrombectomy vs. Combined Treatment With Intravenous Thrombolysis in the Extended Time Window: A Target Trial Emulation.

European journal of neurology·2026
Same journal

Pharmacological Treatment of Cerebellar Ataxia in Pediatric Ataxia-Telangiectasia: A Systematic Review.

European journal of neurology·2026
Same journal

Intensive Rehabilitation With Adjunctive Bilateral Anodal tDCS in Post-Stroke Dysphagia: A Multicenter Randomized Controlled Trial.

European journal of neurology·2026
Same journal

Distal Agrin (AGRN) Congenital Myasthenic Syndrome With Mitochondrial Dysfunction.

European journal of neurology·2026
See all related articles

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • Mitochondriopathies (MCPs) stem from genetic mutations or external factors, impacting cellular energy production.
  • These disorders often manifest chronically with multi-systemic involvement, affecting individuals from birth to adulthood.
  • Impaired respiratory chain complex activity is a common hallmark, leading to reduced cellular energy output.

Purpose of the Study:

  • To review the complex nature of mitochondrial disorders (MCPs).
  • To highlight the diagnostic challenges posed by the wide spectrum of MCP presentations.
  • To underscore the potential for improved diagnostics and therapies through enhanced pathophysiological understanding.

Main Methods:

  • Literature review of mitochondrial disease mechanisms and clinical manifestations.

Related Experiment Videos

  • Analysis of genetic and exogenous causes of primary and secondary MCPs.
  • Compilation of affected organ systems and associated symptoms.

    • Main Results:

    • MCPs present with diverse symptoms affecting nearly every organ system, including neurological, cardiac, endocrine, and ocular systems.
    • Diagnostic difficulties arise from the heterogeneity in onset, progression, and clinical presentation.
    • While no cure exists, management of secondary complications is crucial.

    Conclusions:

    • MCPs are complex disorders requiring a high index of suspicion, especially in unexplained multisystem diseases.
    • Further research into the pathophysiology of MCPs is vital for advancing diagnostic strategies.
    • Improved understanding paves the way for potential future causative treatments for mitochondrial diseases.